Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 42% ± 19% | |
| GABAergic neuron | 6 studies | 33% ± 9% | |
| endothelial cell | 3 studies | 27% ± 14% | |
| astrocyte | 3 studies | 19% ± 3% | |
| oligodendrocyte | 3 studies | 16% ± 1% | |
| interneuron | 3 studies | 39% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 35% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 88% | 603.92 | 216 / 245 | 72% | 12.16 | 362 / 502 |
| brain | 74% | 3734.46 | 1955 / 2642 | 86% | 29.37 | 604 / 705 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.79 | 1 / 1 |
| intestine | 40% | 95.76 | 383 / 966 | 18% | 1.53 | 93 / 527 |
| pancreas | 0% | 0 | 0 / 328 | 56% | 4.98 | 99 / 178 |
| lung | 33% | 82.08 | 188 / 578 | 13% | 0.69 | 153 / 1155 |
| stomach | 21% | 51.61 | 75 / 359 | 22% | 1.58 | 62 / 286 |
| esophagus | 9% | 14.73 | 133 / 1445 | 26% | 2.46 | 48 / 183 |
| uterus | 0% | 0 | 0 / 170 | 21% | 1.54 | 97 / 459 |
| adrenal gland | 6% | 7.25 | 16 / 258 | 13% | 2.79 | 29 / 230 |
| bladder | 0% | 0 | 0 / 21 | 17% | 1.27 | 87 / 504 |
| skin | 11% | 49.88 | 200 / 1809 | 1% | 0.02 | 6 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.23 | 4 / 45 |
| ovary | 1% | 0.99 | 1 / 180 | 8% | 0.20 | 33 / 430 |
| breast | 1% | 2.11 | 3 / 459 | 4% | 0.16 | 45 / 1118 |
| liver | 2% | 6.61 | 4 / 226 | 2% | 0.40 | 7 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| kidney | 1% | 2.18 | 1 / 89 | 0% | 0.02 | 3 / 901 |
| thymus | 0% | 0 | 0 / 653 | 1% | 0.12 | 5 / 605 |
| heart | 0% | 0.49 | 2 / 861 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.33 | 2 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.14 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0007409 | Biological process | axonogenesis |
| GO_0007165 | Biological process | signal transduction |
| GO_0001764 | Biological process | neuron migration |
| GO_0007586 | Biological process | digestion |
| GO_0042755 | Biological process | eating behavior |
| GO_0005615 | Cellular component | extracellular space |
| GO_0030424 | Cellular component | axon |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005179 | Molecular function | hormone activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0051428 | Molecular function | peptide hormone receptor binding |
| GO_0005184 | Molecular function | neuropeptide hormone activity |
| Gene name | CCK |
| Protein name | CCK protein (Cholecystokinin) (cDNA FLJ76519, highly similar to Homo sapiens cholecystokinin (CCK), mRNA) Cholecystokinin (CCK) [Cleaved into: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)] |
| Synonyms | hCG_28858 |
| Description | FUNCTION: This peptide hormone induces gall bladder contraction and the release of pancreatic enzymes in the gut. Its function in the brain is not clear. Binding to CCK-A receptors stimulates amylase release from the pancreas, binding to CCK-B receptors stimulates gastric acid secretion. . |
| Accessions | ENST00000434608.1 ENST00000396169.7 P06307 ENST00000334681.9 Q6FG82 |
